The consultation included an honest discussion of where the evidence was strong (topical applications, tissue repair contexts) and where it was thinner (systemic injectable use for aesthetic outcomes)
or losses arising from improper storage, handling, transfer, or application
[DOI] [PMC free article] [PubMed] [Google Scholar] 34.Chintamaneni S, Finzel K, Gruber BL
By stimulating the testes directly, it helps maintain their function during the transition period while the pituitary slowly resumes normal LH production
Despite promising preclinical results and its favorable safety profile, BPC 157 lacks FDA approval, necessitating further clinical trials to validate its therapeutic potential and establish comprehensive safety data